This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics US
December 15 - 18, 2024
Marriott Marquis San DiegoLive In-Person Event: December 15 - 18, 2024

Bob Chen, PhD
Senior Director, Discovery Systems at OmniAb


Bob Chen is Senior Director of Discovery Systems at OmniAb. Dr. Chen leads the development of our xPloration® platform. Dr. Chen previously was the Chief Technology Officer and a co-Founder of xCella Biosciences, an antibody discovery and technology company based in Menlo Park, California, that was built on scientific research from Stanford University and MIT and acquired by OmniAb in 2020. Dr. Chen earned a Bachelor’s degree in Chemical Engineering from MIT and a PhD in Bioengineering from Stanford University.

Agenda Sessions

  • Wrangling Diverse OmniAb Antibody Repertoires with OmniDeep